Oxford University's technology transfer company, Isis Innovation, has launched range of new assays for obesity research - tools that can be used to identify potential drug candidates. A team led by Oxford's Prof Chris Schofield has developed the assays. They are based on the group's pioneering work which identified a gene and an enzyme strongly implicated in obesity.